John E. Feenstra

Brisbane, QLD, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): a randomised, double-blind, placebo-controlled phase 3 study.

Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): a randomised, double-blind, placebo-controlled phase 3 study.

Journal: Lancet (London, England)
Published: April 22, 2026

Phase 2a/b randomised placebo-controlled dose-escalation trial of triheptanoin for ataxia-telangiectasia: treating mitochondrial dysfunction with anaplerosis.

Phase 2a/b randomised placebo-controlled dose-escalation trial of triheptanoin for ataxia-telangiectasia: treating mitochondrial dysfunction with anaplerosis.

Journal: EBioMedicine
Published: January 17, 2025

Impact of Left Heart Disease Risk Factors on Outcomes in Pulmonary Arterial Hypertension Therapy.

Impact of Left Heart Disease Risk Factors on Outcomes in Pulmonary Arterial Hypertension Therapy.

Journal: Chest
Published: March 05, 2023

Acute Vasoreactivity Testing and Outcomes in Pulmonary Arterial Hypertension: A Call for Increased Testing.

Acute Vasoreactivity Testing and Outcomes in Pulmonary Arterial Hypertension: A Call for Increased Testing.

Journal: Heart, lung & circulation
Published: January 27, 2022

Chronic thromboembolic pulmonary hypertension in Australia and New Zealand: An analysis of the PHSANZ registry.

Chronic thromboembolic pulmonary hypertension in Australia and New Zealand: An analysis of the PHSANZ registry.

Journal: Respirology (Carlton, Vic.)
Published: December 11, 2020

Use of eHealth in the management of pulmonary arterial hypertension: review of the literature.

Use of eHealth in the management of pulmonary arterial hypertension: review of the literature.

Journal: BMJ health & care informatics
Published: May 14, 2020

Pharmacological Treatment of Pulmonary Arterial Hypertension in Australia: Current Trends and Challenges.

Pharmacological Treatment of Pulmonary Arterial Hypertension in Australia: Current Trends and Challenges.

Journal: Heart, lung & circulation
Published: August 28, 2019

Pulmonary arterial hypertension with below threshold pulmonary vascular resistance.

Pulmonary arterial hypertension with below threshold pulmonary vascular resistance.

Journal: The European respiratory journal
Published: August 21, 2019

Diagnostic delay in pulmonary arterial hypertension: Insights from the Australian and New Zealand pulmonary hypertension registry.

Diagnostic delay in pulmonary arterial hypertension: Insights from the Australian and New Zealand pulmonary hypertension registry.

Journal: Respirology (Carlton, Vic.)
Published: June 26, 2019

Effectiveness of epoprostenol in the management of pulmonary arterial hypertension: findings of an Australian retrospective chart review.

Effectiveness of epoprostenol in the management of pulmonary arterial hypertension: findings of an Australian retrospective chart review.

Journal: Internal medicine journal
Published: June 25, 2019

Retrospective Validation of the REVEAL 2.0 Risk Score With the Australian and New Zealand Pulmonary Hypertension Registry Cohort.

Retrospective Validation of the REVEAL 2.0 Risk Score With the Australian and New Zealand Pulmonary Hypertension Registry Cohort.

Journal: Chest
Published: May 14, 2019

Survival of Idiopathic Pulmonary Arterial Hypertension Patients in the Modern Era in Australia and New Zealand.

Survival of Idiopathic Pulmonary Arterial Hypertension Patients in the Modern Era in Australia and New Zealand.

Journal: Heart, lung & circulation
Published: July 20, 2017
Showing 1-12 of 15

Last Updated: 09/26/2026